首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   224篇
  免费   29篇
儿科学   1篇
妇产科学   3篇
基础医学   40篇
口腔科学   4篇
临床医学   32篇
内科学   36篇
皮肤病学   4篇
神经病学   34篇
特种医学   28篇
外科学   26篇
综合类   1篇
预防医学   14篇
眼科学   2篇
药学   11篇
中国医学   1篇
肿瘤学   16篇
  2023年   1篇
  2022年   5篇
  2021年   2篇
  2020年   4篇
  2019年   11篇
  2018年   10篇
  2017年   11篇
  2016年   7篇
  2015年   12篇
  2014年   12篇
  2013年   11篇
  2012年   10篇
  2011年   10篇
  2009年   10篇
  2008年   9篇
  2007年   15篇
  2006年   8篇
  2005年   10篇
  2004年   6篇
  2003年   8篇
  2002年   6篇
  2001年   6篇
  2000年   4篇
  1999年   9篇
  1997年   1篇
  1996年   1篇
  1995年   3篇
  1994年   1篇
  1992年   5篇
  1991年   5篇
  1990年   1篇
  1989年   5篇
  1988年   5篇
  1987年   3篇
  1986年   2篇
  1985年   3篇
  1984年   4篇
  1983年   4篇
  1982年   3篇
  1979年   1篇
  1978年   1篇
  1976年   3篇
  1975年   1篇
  1973年   3篇
  1961年   1篇
排序方式: 共有253条查询结果,搜索用时 15 毫秒
91.
High-risk neuroblastomas often harbor structural chromosomal alterations, including amplified MYCN, and usually have a near-di/tetraploid DNA index, but the mechanisms creating tetraploidy remain unclear. Gene-expression analyses revealed that certain MYCN/MYC and p53/pRB-E2F target genes, especially regulating mitotic processes, are strongly expressed in near-di/tetraploid neuroblastomas. Using a functional RNAi screening approach and live-cell imaging, we identified a group of genes, including MAD2L1, which after knockdown induced mitotic-linked cell death in MYCN-amplified and TP53-mutated neuroblastoma cells. We found that MYCN/MYC-mediated overactivation of the metaphase–anaphase checkpoint synergizes with loss of p53-p21 function to prevent arrest or apoptosis of tetraploid neuroblastoma cells.  相似文献   
92.
PURPOSE: Glycine has a protective effect in renal and skeletal muscle ischemia. The purpose of this study was to evaluate the effect of glycine in mesenteric ischemia and reperfusion injury in a rat model. METHODS: Twenty-four anesthetized male Sprague-Dawley rats were subjected to 1 hour of mesenteric ischemia followed by 2 hours of reperfusion. Control animals received normal saline solution intravenously at 0.01 mL/g of body weight/h during ischemia and reperfusion. Treated animals received glycine at 0.5, 0.75, or 1.0 mg/g of body weight, dissolved in saline solution and infused at 0.01 mL/g/h for 2 hours. Animals were killed at the end of the experiment, and proximal, middle, and distal segments of the small bowel were isolated. Sections of the segments stained with hematoxylin-eosin were subjected to histologic examination (as per modified Chiu grading system) and morphometric analysis consisting of measurement of bowel wall, muscularis and mucosal thickness, epithelial coverage, and villar circumference. Isometric tension responses to electrical stimulation (10, 30, 50, 100 Hz), high doses of potassium (120 mmol/L), and carbachol (0.1, 0.5, 1.0, 5.0 micromol/L) were recorded in a multimuscle chamber. Statistical analysis was performed with unpaired t test and one-way analysis of variance. RESULTS: The middle and distal segments of the small bowel in glycine-treated animals showed better histologic grade compared with saline solution-treated control rats (P <.05). At morphometric analysis, total thickness, mucosal thickness, and villar circumference ratio were well preserved in the middle and distal segments of the small bowel in the glycine-treated group (P <.05). No significant differences were observed in the proximal bowel segments between glycine-treated and control animals, because the proximal segment was not subjected to much ischemia. No differences were noted in percentage of epithelial coverage. Isometric tension responses evoked by electrical stimulation were greater (P <.05) in the middle and distal segments treated with glycine as compared with control segments. Carbachol-evoked contractions were stronger (P <.05) in the small bowel segments of animals treated with glycine. The responses evoked by 120 mmol/L of potassium were stronger in the distal segments of the small bowel in the glycine-treated group (P <.05). This cytoprotective effect of glycine was not dose-dependent. CONCLUSIONS: Glycine improved mucosal viability in the ischemia and reperfusion injury rat model. Mucosal thickness and villous circumference ratio were reliable objective parameters for evaluation of intestinal ischemia injury. Glycine improved the contractile responses of the bowel segments also, probably by altering the physiologic mechanisms underlying force generation. Further studies are required to elucidate the mechanism of the cytoprotective action of glycine.  相似文献   
93.
94.
95.
CardioVascular and Interventional Radiology - Lung parenchymal abscesses represent an uncommon pathology with high mortality if untreated. Although most respond well to antibiotics, the optimal...  相似文献   
96.
The management of multiple myeloma (MM) is challenging: An assortment of available drug combinations adds complexity to treatment selection, and treatment resistance frequently develops. Given the heterogeneous nature of MM, personalized testing tools are required to identify drug sensitivities. To identify drug sensitivities in MM cells, we established a drug testing pipeline to examine ex vivo drug responses. MM cells from 44 patients were screened against 30 clinically relevant single agents and 44 double‐ and triple‐drug combinations. We observed variability in responses across samples. The presence of gain(1q21) was associated with low sensitivity to venetoclax, and decreased ex vivo responses to dexamethasone reflected the drug resistance observed in patients. Less heterogeneity and higher efficacy was detected with many combinations compared to the corresponding single agents. We identified new synergistic effects of melflufen plus panobinostat using low concentrations (0.1–10 nm and 8 nm, respectively). In agreement with clinical studies, clinically approved combinations, such as triple combination of selinexor plus bortezomib plus dexamethasone, acted synergistically, and synergies required low drug concentrations (0.1 nm bortezomib, 10 nm selinexor and 4 nm dexamethasone). In summary, our drug screening provided results within a clinically actionable 5‐day time frame and identified synergistic drug efficacies in patient‐derived MM cells that may aid future therapy choices.  相似文献   
97.
98.
Background: Several studies have suggested a relationship between the age at menarche and risk of asthma development. Objective: To conduct a systematic review and meta-analysis of the relationship between the age at menarche and the risk of asthma. Methods: This systematic review and meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). A pre specified literature search strategy was used to identify studies of potential relevance and independent reviews were carried out by two authors. Raw data was pooled using the software package RevMan to calculate summary odds ratios. The risk of publication bias was assessed graphically by using a funnel plot and the robustness of the overall estimate obtained was assessed by using sensitivity analyses. Results: The searches identified 61 potentially relevant articles of which seven articles, with a total of 22?859 subjects, matched the inclusion criteria for the meta-analysis. Pooling of the seven studies showed that girls with early menarche (<12 years) had an increased risk of asthma relative to girls with late menarche; random effects odds ratio?=?1.37 (1.15–1.64), (p?=?0.0005). Substantial heterogeneity was revealed (I2?=?55%). Sensitivity analysis showed that the risk estimate was not markedly changed when excluding any of the studies. The funnel plot did not indicate publication bias. Conclusions: Early menarche appears to be associated with increased risk of asthma. Hormonal, immunological, genetic and environmental factors may act in a developmental context to explain this relationship. Future studies are warranted to further determine the mechanisms responsible for this observation.  相似文献   
99.
Microradiography of nephrons in kidneys perfusion-fixed with glutaraldehyde permits examination of large numbers of nephrons. This technique was applied to rabbits between one and 14 days following unilateral ureteral ligation. Kidneys without ureteral occlusion served as controls. By two days after ureteral obstruction there was dilatation of the ducts of Bellini and papillary collecting ducts. At three to four days there was splaying and tortuosity of the loops of Henle. By eight to 10 days the proximal straight tubules were noted to be dilated and helically twisted. After two weeks of ureteral obstruction there was dilatation of Bowman's space with encroachment on the glomerular capillary tuft. At this time many proximal convoluted tubules began to show atrophic changes. These morphologic alterations may due in part to back pressure on the nephrons, with retrograde progression as the duration of urinary tract obstruction is increased. The distal convoluted tubule and the descending limb of the loop of Henle were not noted to be abnormal during the study.  相似文献   
100.
A comparison of Paraghurt tablets (freeze-dried culture of Streptococcus faecium) and placebo was carried out in patients with irritable bowel syndrome in a double-blind trial in Danish general practices. Fifty-four patients (42 females and 12 males) with an average duration of the disease of seven years were treated for four weeks. The clinical symptoms were registered prior to the treatment and after two and four weeks. The clinical effect was assessed according to changes in number of abdominal symptoms, the patients' registrations on rating scales, and the physicians' overall estimations. According to all three parameters a markedly better effect of Paraghurt was seen. Thus, after four weeks 81% of the Paraghurt- and 41% of the placebo-treated patients had improved according to the physicians' overall assessment (p = 0.002). The result of the trial suggests that Paraghurt is a valuable alternative in the treatment of irritable bowel syndrome.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号